Company intelligence / Profile preview

Sichuan Shangrui Biopharmaceutical

Chengdu, Sichuan, China

Ownership: Private
Development stage: Other

Overview

Sichuan Shangrui Biopharmaceutical is a Chinese biotechnology company headquartered in Chengdu, specializing in the discovery and development of innovative small molecule therapeutics. Founded in 2018, the company focuses on high-prevalence conditions such as hyperuricemia, gout, and various cancers. Its lead program, SR-1378, is a potent URAT1 inhibitor designed to manage uric acid levels more effectively than existing treatments. The company operates within the Chengdu Medical City ecosystem, utilizing advanced medicinal chemistry and pharmacology platforms to advance its pipeline from discovery through clinical development. Sichuan Shangrui Biopharmaceutical aims to provide high-quality, affordable innovative drugs to patients globally.

Therapeutic areas: RheumatologyMetabolic DisordersOncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Sichuan Shangrui Biopharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sichuan Shangrui Biopharmaceutical.

Explore the full profile